In a conversation with GRIP’s Kevin Kinsella, PwC’s Brian Riewerts and Michael Reyes outline how life sciences companies can move from fragmented risk management to enterprise‑wide intelligence – and why the next five years will separate risk leaders from laggards. They covered:
- siloed compliance investments and why risk effectiveness